Bikaji Foods Q2 Results: Profit rises by 13% to Rs 61.19 crore, revenue up 18.5% YoY on festive demand

Bikaji Foods International Ltd released its fiscal second quarter earnings with profit at Rs 69.16 crore, up 13.0 per cent in comparison to Rs 61.19 crore during the same period of previous financial year. It posted revenue from operations at Rs 721.17 crore, up 18.5 per cent as against Rs 608.69 crore during the corresponding quarter of FY24. The company EBITDA stood at Rs 89.6 crore, up 3 per cent YoY. Bikaji Foods posted volume growth of 15.0 per cent YoY.

For H1, Bikaji Foods posted revenue growth of 18.6 per cent to Rs 1293.30 crore, with volume growth of 15.5 per cent. EBITDA for the period grew by 29.2 per cent to Rs 198.30 crore with a margin of 15.3 per cent (up 126 bps YoY) led by strong festive demand. Profit for H1 stood at Rs 126.60 crore. 

Also ReadRestaurants beckon customers to outlets with value meals

Performance across segments

Also Read Bajaj Finserv Q2 Results: Profit rises by 8.2% to Rs 2,086.97 crore, revenue up 29.5% YoY PepsiCo Bottler Varun Beverages posts Q3 profit at Rs 619.61 crore, revenue rises by 25.3% YoY Mphasis Q2 Results: Profit rises by 8% to Rs 423.33 crore, approves investment of $30 million in subsidiary L&T Tech posts Q2 profit at Rs 319.60 crore, revenue rises by 7.8% YoY; FY25 guidance maintained

Bikaji Foods’ ethnic snacks category posted revenue growth of 10.5 per cent YoY during the second quarter of FY25, which constituted 63.8 per cent of the overall revenue. Packaged sweets posted revenue growth of 22.0 per cent YoY, making up 17.5 per cent of overall revenue. Western snacks recorded revenue growth of 23.2 per cent YoY and contributed to 8.3 per cent of the overall revenue. Papad, meanwhile, grew by 24.2 per cent YoY. 

Deepak Agarwal, Managing Director, Bikaji Foods International Limited, “We are delighted to inform our stakeholders that our company has demonstrated strong performance across all the categories. This quarter we have witnessed a significant jump in revenue and profit margins. This surge in growth is due to the demand in Ethnic Snacks and Packaged Sweets on account of Festive seasonality impact. Overall contribution of Packaged Sweets has jumped to 17.5 per cent this quarter, which is again due to festive play.”

“Despite facing significant inflationary challenges,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth